• Huge company network with some 1.5 million overall health treatment companies
• Sturdy integration with drug and dental with dental designs supplied in all 50 states
Negatives:
⁃ A big footprint, but its personal and family members ideas are constrained to 16 states
⁃ Over average variety of client problems
(Picture: askarim/Shutterstock.com)
9. MOLINA Health care
INSURE.COM Suggests:
Pros:
• It has earned its members’ rely on
• The wide greater part of buyers system to renew their policies
Cons:
⁃ Protection is confined to government-sponsored packages
⁃ Protection is accessible in a lot less than 20 states
(Picture: Casimiro PT/Shutterstock)
8. BLUE CROSS BLUE Defend OF FLORIDA
INSURE.COM Claims:
Professionals:
• Scored properly for minimal deductibles
• Comprehensive company network all through Florida
• Nationwide entry to wellness treatment by the Blue Cross Blue Defend umbrella
Downsides:
⁃ Other insurers rated higher for affordability
⁃ Strategies mostly limited to Sunshine Point out inhabitants
7. BLUE Protect OF CALIFORNIA
INSURE.COM Says:
Execs:
• Blue California rated among the the best insurers for affordability
• It was among the the leading wellness insurance vendors primarily based on customer fulfillment
• Buyers also rated it finest in our survey for coverage offerings
Drawbacks:
⁃ Though clients seemed to be pretty joyful with the companies they gained, it scored among the the least expensive in our survey for renewals
⁃ It’s largely limited to California citizens
6. BLUE CROSS BLUE Defend OF MICHIGAN
INSURE.COM Suggests:
Professionals:
• It been given high marks from the NCQA
• It has a lower level of grievances
• It ranked in the leading 50 {08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of the checklist for shopper fulfillment
Cons:
⁃ It was not as probably to be advised to many others
⁃ Only available to Michigan citizens or employees with companies headquartered there
5. HUMANA
INSURE.COM Suggests:
Pros:
• Rated highly for customer satisfaction
• Much more than 90{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of consumers would recommend it
• It gives wellbeing insurance policy throughout the nation
Disadvantages:
⁃ Other insurers had larger renewal scores
⁃ Not rated as very as some competitors for affordability
4. ANTHEM
INSURE.COM Says:
Pros:
• Rated superior for renewals
• Huge service provider networks
• Good for people today who like a a single-quit store for all their wellness, dental, eyesight and pharmacy desires
Downsides:
⁃ Doesn’t have the optimum marks for consumer fulfillment
⁃ Clients didn’t give its coverage choices the strongest marks
(Picture: Jonathan Weiss/Shutterstock.com)
3. AETNA
INSURE.COM Claims:
Professionals:
• Rated highly for affordability
• Between the most dependable wellbeing insurers
• It’s expanding its digital offerings
Drawbacks:
⁃ Consumers didn’t price its plan choices as highly as other providers
⁃ Its provider network was also not rated as strongly as some others
(Picture: JHVEPhoto/Shutterstock)
2. UNITEDHEALTHCARE
INSURE.COM Claims:
Professionals:
• Sizing can issue, and UnitedHealthcare unquestionably has it with a significant membership foundation and coast-to-coastline protection
• Consumers give it higher marks for the vary of its policy choices
• It’s great for worldwide travelers and expats with far more than 5 million users in its Global system
Disadvantages:
⁃ Most customers were being pleased, but it didn’t score as substantial as some of its opponents
⁃ Its service provider network is large, but consumers did not rank it all that remarkably
(Photograph: Ken Wolter/Shutterstock)
1. KAISER PERMANENTE
INSURE.COM States:
Pros:
• Achieves the best grades for shopper gratification
• Superior buyer loyalty with the best rating for trustworthiness
• Sturdy portfolio and range of policy offerings
Disadvantages:
⁃ When gratification is large, it is not a reduced-cost provider
⁃ Not readily available in all states
(Photo: Sundry Images/Shutterstock.com)
Deciding upon the best wellness insurance policy company is not for the faint-hearted. The course of action will take a wonderful offer of time, and encompasses much more aspects than dollar signs. “Cost is critical, but it does not convey to the complete story,” suggests Chris Homosexual, CEO of Evry Health and fitness, who endorses supplying major consideration to “each plan’s innovation, affordability, entry and contribution strategy, every of which have a immediate effect on price tag.”
To that stop, the editors at Insure.com have compiled a study rating the finest insurance corporations primarily based on several features, including ease of services, lower deductibles, and trustworthiness.
The survey collected info from a wide range of resources. Primarily, Insure.com polled much more than 1,500 coverage shoppers, asking to quality their carriers on purchaser gratification, simplicity of provider and policy choices. Respondents had been also asked to rank their insurer’s leading a few characteristics, and no matter if or not they would advocate their carrier to an individual else.
Insure.com also appeared at AM Very best financial security scores and Nationwide Committee for High-quality Assurance scores.
Kaiser Permanente took the guide in the survey’s breakout classes, becoming ranked as best for customer pleasure, ease of assistance, policy choices (tied with Blue California), most trustworthy, and most probable to be proposed to many others.
“Consumers definitely want to help you save money and acquire a lower high quality when selecting an insurance organization. Nevertheless, it is significant to also contemplate aspects such as financial scores, regulatory compliance and purchaser satisfaction,” claims David Marlett, an Insure.com editorial advisor and handling director for Brantley Threat & Coverage Center at Appalachian Point out College.
There’s a indicator at the University of Central Florida (UCF) College of Medication that reads, “The lesson you discover nowadays will preserve someone’s lifetime tomorrow. Pay attention!” These two sentences embody Dr. Deborah German’s enthusiasm and her drive to develop the UCF health care faculty in affiliation with an necessary lover: VA.
Dr. German, vice president for Wellness Affairs and founding dean of the UCF School of Medication, is the powerhouse powering Central Florida’s Lake Nona clinical neighborhood, one of VA’s robust educational affiliations to coach foreseeable future overall health pros.
Lake Nona commenced with a vision to build a new healthcare university with the latest technological innovation to educate various college students in partnership with a new VA health care center in Central Florida.
When the UCF College or university of Medication/Orlando VA partnership started, neither entity even experienced a creating. But alongside one another, German and Orlando VA leadership team solid a aspiration that would lead to education opportunities for UCF College or university of Medication pupils at a co-positioned tertiary care VA healthcare facility.
Knowledge helps them comprehend Veterans
Just one particular ten years later, this vision is a fact that has produced 956 medical professionals who continue to care for Veterans in VA and in communities throughout the country. In truth, just about every UCF health-related scholar completes a medical rotation at the Orlando VA with a number of them also rotating by Bay Pines VA, an encounter that can help them recognize Veterans and the sacrifices they have created for our place.
“I realized that I required to be right here to establish this century’s premier professional medical college, one particular that could leapfrog above all the greatest health-related colleges in the nation and construct some thing improved. I always realized that VA needed to be portion of that vision,” stated German, who also serves on VA’s Nationwide Tutorial Advisory Council. “If you glance nationally at professional medical universities, you will find that the quite greatest are affiliated intently with VA hospitals and, optimally, they’re on the identical campus. So, when the option came to husband or wife with a VA, there was no query in my mind that that was what we desired to do.”
Dr. Deborah German
German, who concluded aspect of her clinical education at Roxboro VA, went on to serve as affiliate dean of Professional medical Education at Duke College and as senior affiliate dean of Professional medical Training for Vanderbilt University. Through those medical schools’ affiliations with VA, she realized very first-hand the value of VA coaching experiences for learners and college alike.
Allows pupils know what can be
“VA is these kinds of a excellent and exceptional encounter for trainees,” explained German. “The point that would make VA so valuable in a medical schooling is that it is complete and, in our region, wellness treatment is fractionated. So, when our students and residents are understanding in a VA [facility], they’re learning a system that they can not see wherever else and it genuinely does give them a distinct look at of well being treatment. It assists them know what can be.”
Orlando VA Inner Medicine Residency Software Director and UCF Professor Dr. Abdo Asmar agreed. He said that, because VA is these types of an integrated technique, trainees master to treatment for all the sophisticated requires of Veterans—clinical, psychological, emotional and social.
“One of the items I take pleasure in the most when I’m interacting with citizens or learners is to instruct them about how to feel about considering,” Abdo explained. “Despite all the advancement in technological know-how, medication is nevertheless an artwork as much as it is a science. To be equipped to observe excellent medication, you have to have a holistic tactic to affected individual care. I feel that functioning in VA aids us concentrate on that.”
“Working with Veterans gave me a perception of reason.”
VA’s approach to client care, put together with opportunities to teach and take part in investigate, have led various UCF Faculty of Drugs graduates, like Dr. Richard Henriquez, to keep on their careers in VA soon after their training is finish.
Henriquez, who accomplished both equally his residency and main residency at the Orlando VA, is now on staff there and is school at the UCF College or university of Drugs.
“Working with Veterans actually gave me a sense of function,” mentioned Henriquez. “I want to make a difference, not just for my clients, but train the health-related learners, educate the people how to be the most effective health practitioner.”
The Lake Nona clinical neighborhood, anchored by UCF College of Medication and Orlando VA, is now known throughout the U.S. as a model local community for health and fitness, teaching and research. Lake Nona also encompasses UCF’s School of Nursing and Higher education of Dental Medication, as properly as the University of Florida University of Pharmacy, all associates of Orlando VA for schooling upcoming well being treatment professionals.
“We’re growing up together,” German concluded. “We built our structures about the similar time. We started off selecting our doctors about the exact same time. We are just one, and we imagine about our partner’s demands and we check out to fulfill them. If our companion thinks about our desires and they consider to satisfy them, we stop up with something that’s way much better than anything we could do on our own. It is about the pupils, the inhabitants, the analysis. But all of that is actually about the client. And at VA, we have quite specific individuals.”
Find out extra
All through VA Wellbeing Professions Schooling Week, March 13 – 17, VA recognizes the extra than 118,000 HPTs who prepare every year in VA and the much more than 1,400 instructional establishments that spouse with VA to teach upcoming wellness specialists.
These academic affiliations, some of which began far more than 75 many years in the past, are coordinated by VA’s Office environment of Academic Affiliations (OAA). Find out much more about VA’s educational mission by looking at this video and going to the Office of Educational Affiliations site.
The challenge of accelerated clinical developments
In France, decisions for reimbursement taken by the Ministry of Health are based on appraisal by an independent Health Technology Assessment body (HTAb): the ‘Haute Autorité de santé’ (HAS). HAS grades the clinical added value of any medicinal product for which a manufacturer seeks reimbursement. This appraisal considers different types of clinical and patient-centred outcomes, including patient-reported ones. Under certain conditions, a concomitant economic assessment which accounts for patients’ preferences in the form of utility values is also performed.
As providing fast access to breakthrough therapies is a critical expectation from patients, clinicians and health policy makers, the European Medicines Agency and the Food and Drug Administration have established various accelerated approval pathways. These procedures lead to conditional approvals frequently based on uncontrolled (ie, single arm) pivotal trials.1–4 Approvals based on uncontrolled trials are also motivated by randomisation sometimes being considered unfeasible or unethical, or because the pathophysiological rationale is assumed to be important when proving effectiveness (eg, a treatment with molecular target in oncology).5 6
However, expected benefits based on uncontrolled trials as evidence are frequently not confirmed. The results of meta-epidemiological studies illustrate that appraisals based on such evidence entail a high level of uncertainty leading to ethical concerns.7 8 For patients, this may have deleterious consequences such as the use of products for which the benefits remain unknown,9 10 the overestimation of benefits with no further confirmation11 12 or the increased risks of adverse events.12 13 This high level of uncertainty may also impact health system sustainability.
While ensuring rapid access to valuable treatments is of utmost importance to patients, maintaining an adequate balance with the performance of relevant HTA in this context is highly challenging. Thus, the French Minister of Health requested HAS to provide recommendations. A consultation of patient associations, academics, manufacturers and various institutions was conducted from October 2021 to January 2022. With the support of an expert committee, a qualitative summary of the consultation has led to the prioritisation of recommendations, which are developed below (details on the consultation process are available in an online supplemental appendix 1).
Need for evidence from comparative designs allowing causal interpretation of treatment effect estimation
Performing relevant HTA requires that an unbiased estimate of the treatment effect is available. Thus, the additional effect must be disentangled beyond effects due to the natural course of the medical condition, the placebo effect, various sources of bias and the effect of alternative(s). To produce such an estimate, the simplest and most consensual methodological choice is a comparison of the treatment of interest to a control by conducting a randomised controlled trial (RCT). Randomising treatment allocation balances both known and unknown confounders between groups, which enables the causal attribution of an observed effect to the investigated treatment. Other characteristics such as blinding and intention to treat analysis principles reduce the risk of bias and thereby lead to an estimation of treatment effect with the highest certainty of results.
Therefore, RCTs should still be systematically considered by manufacturers during clinical development.
Accelerating rapid access to innovative treatments by adapting the traditional RCT design
While RCTs are the gold standard for producing clinical evidence, HAS acknowledges that the strict adherence to the traditional fixed-sample RCT design can lead to long delays before patients access treatments. Several alternatives to the traditional design, such as adaptative designs, platform trials, seamless trials, pragmatic trials or cross-over designs, can be better suited choices for accelerating clinical developments. An overview of main strengths and methodological points of attention is described in table 1. All these adaptations are considered compatible with the principles of RCT design and can produce evidence with high certainty of results.
Table 1
Adaptation of randomised controlled designs leading to good enough certainty of results that can accelerate treatment access to patients
They should, therefore, be encouraged first when considering the issue of balancing rapid access to beneficial medicinal products to patients while performing relevant HTA.
Increasing the certainty of results when uncontrolled trials are pivotal studies
Apart from the exceptional condition where an unequivocal response on a patient-centred outcome for almost all patients compared with an otherwise certain pejorative evolution is observed, the value of uncontrolled trials alone is strongly limited when estimating the effect of a treatment. Nonetheless, market approval relying on uncontrolled trials is prevalent,14 as is the number of dossiers submitted for HTA based on these trials. Thus, HAS proposes points of attention that should be considered providing a manufacturer wants to submit a dossier based on uncontrolled trial(s) only. They are summarised below and are detailed in box 1. Any deviation from these points of attention will further impair the certainty of results.
Box 1
Methodological points of attention HAS should consider when assessing an external comparison between an uncontrolled trial and an external control
Justification of the lack of randomisation
Study design
Early planning during clinical development and before the conduct of the uncontrolled trial of the treatment of interest.
A priori definition of the clinical question, study population, intervention, comparator and outcomes in a protocol and statistical analysis plan.
An emulation of a target trial can enhance eliciting the appropriate clinical question (estimand) and designing the external comparison.
Well-performed systematic review (with eligibility criteria defined a priori) identifying relevant sources for external control.
Choice of the external control
The comparator and external source(s) of data has been chosen independently of the results of the uncontrolled trial, fit best the clinical question (does not arbitrarily favour the treatment of interest) and correspond to standard of care.
Analysis of the results
The study protocol, statistical analysis plan and report allow a transparent and appropriate assessment of the study.
A model for causal inference controlling an appropriate set of confounders and targeting the predefined estimand has been properly specified and estimated.
The model is preferably based on a method using individual patient data only such as propensity scores, g-computation or doubly robust estimation.
Underlying assumptions have been explored and seems to be met (such as positivity, sufficient overlap and sufficient balance for propensity scores).
If ‘trimming’ (ie, excluding patients in areas of the propensity score without overlap) have been performed, the resulting target population for which results can apply is described.
Residual confounding has been explored with analyses such as the use of negative and positive controls, consistency in results when using other external controls, or quantitative bias analysis and excludes a conclusion of no treatment effect.
Study characteristics of the uncontrolled trial and external control are sufficiently similar for excluding other sources of bias such as selection bias, attrition bias, measurement bias.
Safety can be properly documented for both groups.
Grading the clinical added value
Justifying the suitability of the data generation programme
Lack of randomisation is a major deviation from evidence-based medicine principles and should remain an exceptional option. Therefore, a rationale for the lack of randomisation must be provided by the manufacturer. They are invited to discuss the suitability of the evidence data package during European joint scientific consultations or national early dialogues.
Gathering source(s) of data for external comparison
Performing an adequate comparison vs an external control, using for example data from cohorts or other clinical trials, can be an option for mitigating uncertainties in the absence of RCTs. Availability of external controls may be scarce (eg, in case of targeted therapies for very rare mutation(s) in oncology). Real-world data generation should therefore be anticipated by the manufacturer during the early stages of the clinical development if no pre-existing data set has been identified for the comparison.
Performing transparent and appropriate analyses
To follow an hypothetico-deductive approach, external comparison must be planned as early as possible during clinical development. The framework of the emulation of a target trial can help to define the appropriate estimand, eligibility criteria as well as exposition and outcome(s) of the targeted (ie, ideal) RCT that the external comparison tries to emulate.15 It also helps to avoid the occurrence of immortal-time bias that results from a failure to align start of follow-up.
To avoid a post hoc selection, the choice of an external control must be done prior to conducting the trial, after a well-performed systematic search. It must fit the standard of care. The retained external source of data must be chosen because it fits best the research question and not because it would arbitrarily favour the treatment of interest.
When performing an external comparison, the attribution of the observed effect to the treatment (causal statement) supposes the absence of any confounders. It requires a well performed causal inference analysis, suing appropriate methods. Approaches based on the use of individual patient data only are preferred (eg, propensity scores analysis, g-computation, doubly robust estimation). Indeed, population-based adjusted methods using individual patient data from an uncontrolled trial and aggregate statistics from external data are sometimes considered. However, they rely on the assumption of the conditional constancy of absolute effects (ie, the absolute treatment effects are assumed constant at any given level of the effect modifiers and prognostic variables),16 which is unlikely to be met. To select the appropriate set of covariables to use for conditioning the statistical analyses, a well-performed systematic search of prognosis variables, confounders and effect modifiers must be conducted.
The possibility of residual confounding must be discussed. All methods assume exhaustivity of the confounders considered, a property that will ultimately remain unverifiable. This discussion should not be based on expert opinion only and should be documented, for example, using either negative or positive controls, or a quantitative bias analysis. Sources of bias (eg, selection bias, measurement bias) due to the characteristics of the trial and external control(s) must be discussed.
Safety must be properly documented, including for the external control.
Discussion of cross-cutting implications
This paper delineates proposals for an adequate balance between fast access to valuable medicinal products and performing relevant HTA. RCT, as the simplest and most consensual design for allowing causal reasoning, must be systematically considered for clinical development. However, various adaptations of its design, as proposed in table 1, may accelerate clinical development and are encouraged whenever appropriate.
Conducting uncontrolled trials is regularly justified by arguing that randomisation is deemed unfeasible, or that there is a conflict between individual and collective ethics because there is no other alternative than best supportive care. However, results from meta-epidemiological studies showed that RCTs are regularly conducted when investigating rare diseases, even vs placebo, providing clinical equipoise (ie, the genuine uncertainty regarding the benefit of a new treatment) is appropriately explained to patients.17 Urgent response to an emergent disease, or a strong pathophysiological rationale, are also frequently argued to justify the absence of RCTs. But, randomising the first patients when an emergent disease occurs has been considered ethically appropriate for decades, as it leads to the quickest generation of evidence with the highest certainty of results.18 A strong pathophysiological rationale does not necessarily translate into clinical value and what is considered an ‘innovative’ treatment should be based on clinical evidence. Therefore, HAS cannot propose a definitive list of conditions where absence of randomisation would be de facto acceptable.
To some extent, HAS acknowledges that exceptional conditions may exist that make it unreasonable to conduct an RCT. From the HAS perspective, evidence must, however, still comply to a hypothetico-deductive approach allowing causal reasoning. Should an uncontrolled trial with a comparison vs an external control be provided, the methodological points of attention HAS should consider are described in box 1 to reduce uncertainty. Most of these points of attention (sections 2–5 of box 1) allow assessing factual elements according to good clinical and statistical principles. As such, they could be proposed as consistent points of attention applicable by different HTAbs when assessing external comparisons. However, the acceptance of the rationale justifying the lack of randomisation, as well as some elements leading to the appraisal of clinical added value (eg, relevance and magnitude of treatment effect, impact on public health), are relative to the organisation of health systems and must be assessed considering the national context.
A consequence of relying increasingly on uncontrolled trials as pivotal evidence would be a shift in demonstrating the effectiveness of medicinal products during clinical development towards post-approval. In this context, the use of real-world data, as primary or complementary source of data, is a possible way to address remaining uncertainties. Regardless of the source of data, quality of study design is a cornerstone for certainty of results. To close evidence gap quickly, appropriate studies must thus be anticipated and not limited to uncontrolled designs.19 Usage of real-world data and compliance to RCT design should not be seen as antinomic. When appropriate, the conduct of RCTs can be facilitated by collecting some of the necessary data from pre-existing databases (see table 1). In addition, HAS calls for greater transparency in the whole process of generating evidence through initiatives such as registered report publications, data and clinical study reports sharing.20
Finally, HAS will remain attentive to emerging methods to reduce evidence gaps and accelerate clinical developments. In particular, the increasing use of artificial intelligence, in silico trials and disease modelling, might become a complementary path to optimising clinical development, as illustrated by CRESIM in helping to choose the best design in rare diseases.21 22
Conclusion
Decisions for reimbursement in France are based on an assessment and appraisal process performed by an independent HAS committee which includes healthcare providers, methodologists and patients’ representatives. Members of HAS and especially this committee are eager to secure rapid patient access to valuable medicinal products and that must be weighed against the duty to propose treatment with a clear demonstration of their clinical added value. As evidence-based medicine is an impartial decision model for coverage authorisations and as causal reasoning is essential for continuous improvement of care, HAS reaffirms the importance of RCTs to establish the value of new treatments. However, to balance rapid access for patients with evidential uncertainties, the traditional fixed-sample RCT design can be adapted. Moreover, properly conducted external comparisons as detailed in this paper may represent reasonable alternatives under exceptional conditions.
Welcome to The Cybersecurity 202! Minor spoiler for the finale of “The Last of Us”: Fighting off a zombie while giving birth is super metal.
Reading this online? Sign up for The Cybersecurity 202 to get scoops and sharp analysis in your inbox each morning.
Below: House leaders ask for information on the DC Health Link breach, and a Cambodian cybersecurity law is stirring controversy. First:
Cerebral disclosure shows vulnerability of online mental health data, risk of tracking tools
A company that provides online therapy services acknowledged last week that its customers’ sensitive health information had been sent to third-party firms, illustrating the risks for mental health data and calling attention to a problematic privacy practice.
The telehealth provider, Cerebral, sent letters to more than 3 million users on March 6 about the incident, then followed that with a notice to the Department of Health and Human Services. The company had been sharing user data with Google, Facebook parent Meta, TikTok and others via tracking “pixels.”
“On January 3, 2023, Cerebral determined that it had disclosed certain information that may be regulated as protected health information,” the notice reads, with the information ranging from IP addresses to what services someone selected.
The privacy practices of Cerebral and two other telehealth companies had already drawn congressional attention. Cerebral also is facing scrutiny from HHS under a law that governs exposure of health-care information.
Cerebral said it began using the trackers when it began operations in 2019. Such trackers can often provide information with few checks to outside companies. According to an HHS list of cases it’s investigating that involve unsecured protected health information, the 3.2 million affected individuals makes it the second-biggest case so far this year.
The incident could face scrutiny by regulators like the Federal Trade Commission, as data protection officer and privacy lawyer Whitney Merrill (a former FTC attorney) notes:
Online therapy company BetterHelp reached a settlement with the FTC last week for $7.8 million for sharing health data with third parties for advertising reasons. The FTC also barred it from sharing the health data going forward.
“I thought I was at this point hard to shock,” Ari Friedman, an emergency medicine physician at the University of Pennsylvania and digital health privacy researcher, told the publications in response to their findings. “And I find this particularly shocking.”
Last month, five senators sent letters to the heads of Cerebral, Monument and Workit, which were mentioned in the Markup/STAT story.
“Recent reports highlight how your company shares users’ contact information and health care data that should be confidential,” the letter from Sens. Amy Klobuchar (D-Minn), Susan Collins (R-Maine), Maria Cantwell (D-Wash.) and Cynthia M. Lummis (R-Wyo.) reads. “This information is reportedly sent to advertising platforms, along with the information needed to identify users. This data is extremely personal, and it can be used to target advertisements for services that may be unnecessary or potentially harmful physically, psychologically, or emotionally.”
The senators asked the three companies to provide a list of all the trackers they used, what questions users might be asked and more.
Cerebral’s notice, alerting of the “privacy breach” under the Health Insurance Portability and Accountability Act, outlined what it has done in response. That includes offering free credit monitoring, a common standard response to data breaches that consumer advocates say doesn’t go far enough.
“Upon learning of this issue, Cerebral promptly disabled, reconfigured, and/or removed the Tracking Technologies on Cerebral’s Platforms to prevent any such disclosures in the future and discontinued or disabled data sharing with any Subcontractors not able to meet all HIPAA requirements,” Cerebral said. “In addition, we have enhanced our information security practices and technology vetting processes to further mitigate the risk of sharing such information in the future.”
Malicious hackers have a history of going after mental health information. Such data can also be valuable to advertisers.
The Cerebral case follows an incident last month where a ransomware gang, Vice Society, published a trove of the Los Angeles Unified School District’s current and former student mental health records on the dark web.
In one of the most prominent cases involving the breach of mental health records, hackers who stole data about tens of thousands of patients from Finish psychotherapy practice Vastaamo tried to extort ransoms out of individual patients.
House leaders ask for information on breach of congressional health insurance platform
The FBI and U.S. Capitol Police are investigating the breach of D.C. health insurance marketplace DC Health Link, which is used by thousands of people — including members of Congress and their staff, multiple outlets report. Top House lawmakers are also asking for answers.
House Speaker Kevin McCarthy (R-Calif.) and Minority Leader Hakeem Jeffries (D-N.Y.) sent a letter to Mila Kofman, the DC Health Benefit Exchange Authority’s executive director, last Wednesday after the breach was confirmed, Margaret Barthelreported for DCist. They requested answers about when the group will be notifying affected users about their stolen data and asked for additional steps about how to safeguard the exchange, among other things.
The data that was stolen contained the info of a former national security official, as well as employees of lobbying firms, CyberScoop reporters AJ Vicens and Tonya Riley reported last week. “The leaked data includes names, email addresses, dates of birth, home addresses, social security numbers and details about insurance policies,” they write in the story.
SEC reaches settlement with Blackbaud over misleading ransomware disclosures
South Carolina-based data management software firm Blackbaud agreed to pay $3 million to the U.S. Securities and Exchange Commission to settle charges over misleading claims about a 2020 ransomware attack, David Jones of Cybersecurity Dive reports.
The SEC said the company failed to notify regulators in an August 2020 quarterly report about the scope of a ransomware attack that occurred a month earlier. In July, the company said ransomware attackers did not access Social Security numbers and bank account details. When employees found that sensitive information was stolen, they didn’t tell upper management, according to the SEC.
Blackbaud “failed to disclose the full impact of a ransomware attack despite its personnel learning that its earlier public statements about the attack were erroneous,” David Hirsch, who leads the SEC Enforcement Division’s Crypto Assets and Cyber Unit, said in a statement.
In a statement from Blackbaud CFO Tony Boor that was provided to Jones, Boor said the company “is pleased to resolve this matter with the SEC and appreciates the collaboration and constructive feedback from the commission as the company continuously improves its reporting and disclosure policies.”
Leaked draft law highlights Cambodian government’s move to expand censorship authority
A leaked proposal of a new cybersecurity law would expand the Cambodian government’s ability to seize equipment, initiate searches and prosecute entities that are unable to mitigate cybersecurity threats, Rest of World’s Fiona Kelliher reports.
The 13-page draft law — which was dated Sept. 2, 2022 — wasn’t previously made public, and experts said the bill’s authority expands to both local and international companies, Kelliher writes.
Cambodia in 2018 reportedly faced an increased in hacking attempts leading up to its national elections. Critics said the draft law is meant to protect the current Cambodian regime, and some said it could be abused as the country’s government seeks to crack down on critics ahead of the country’s next round of national elections in July. The law is meant to apply to the majority of public and private entities operating in Cambodia who provide services in sectors such as banking and finance, telecommunications and health care.
Cambodia’s Ministry of Post and Telecommunications would oversee the law. A spokesperson from the ministry told Kelliher “the law is still in draft, and the team is working hard to review the comments from all stakeholders.”
The Senate Homeland Security and Governmental Affairs Committee will hold a 10 a.m. hearing Thursday to examine cybersecurity risks in the health-care sector.
Watch Much larger Impression Representatives from USTTI converse with Terri Imus, RN (foreground suitable) as a digital EKG display screen is handed all-around. The 3-working day occasion showcased various facets of digital overall health systems at UAMS.
Impression by Benjamin Waldrum
| Associates from the United States Telecommunication Instruction Institute (USTTI) visited the College of Arkansas for Medical Sciences’ (UAMS) Institute for Digital Wellness & Innovation (IDHI) as portion of a 3-day digital wellness instruction study course held March 7-9.
13 intercontinental well being and know-how experts converged on the UAMS Very little Rock campus to discover more about applying electronic wellbeing procedures in their international locations.
Several visitors seem at a dwell, digital exhibit from an otoscope.Benjamin Waldrum
“It has been a privilege for the USTTI to associate with UAMS to provide environment course training for 13 international officials,” stated James O’Connor, USTTI chairman and CEO. “The contributors from Costa Rica, Ghana, Hungary, Namibia, Nepal, Paraguay, Rwanda, Thailand, Uganda and Vietnam are main electronic well being initiatives in their nations around the world. The data they obtained this week alongside with the systems and strategies they have been uncovered to will be incorporated into their work and used to preserve lives when they return house.”
The study course, entitled “Developing a Multiple Website Digital Health Community,” is a collaboration of USTTI and UAMS. The class gives a extensive overview for developing, producing and providing education and learning and clinical providers applying digital wellbeing technological innovation. This contains schooling from UAMS school and personnel on technologies and their procedure, academic programming and marketing, as effectively as visits to UAMS digital overall health community websites.
Electronic health is delivering wellness care through engineering this sort of as intelligent telephones, interactive dwell video clip, wearable equipment and private personal computers. It reduces the value of health and fitness care and increases access for people, specifically in a rural atmosphere like Arkansas. The institute’s digital wellbeing community connects additional than 500 Arkansas hospitals and clinics with electronic health and fitness, continuing health care and public well being training, and investigation through interactive video.
“It was a enjoyment to meet with colleagues from around the earth who are passionate about creating electronic overall health options,” explained Joseph Sanford, M.D., director for IDHI. “I hope that their practical experience was worthwhile and appear ahead to continued partnership with USTTI.”
Above a few days, attendees bought a crash study course in digital wellness, including an overview of the institute and its courses, as well as conversations on business enterprise strategies and economic growth. Classes bundled how digital health and fitness networks are developed and maintained, making use of the UAMS e-Link network as an illustration.
A visitor listens to a heartbeat in serious time, transmitted from a specially outfitted stethoscope.Benjamin Waldrum
Attendees later on broke into teams to tour the institute’s call heart and telehealth training centre, as effectively as the UAMS neonatal intense treatment device and its telenursery program, a component of the institute’s Higher-Danger Being pregnant System. The tours had been interactive, allowing particpants to find out about electronic health instantly, this sort of as devices that can transmit live information or video of heartbeats, EKGs and NICU coaching simulators.
“Sharing with other folks what we do, what we have completed, along with our long term jobs is a terrific privilege,” reported Wanda Standridge, RN, BSN, the get in touch with center’s director. “I hope that our practical experience and growth can present inspiration, answers and lay the groundwork to help in launching the same kinds of packages, where ever they are essential.”
“We adore serving to persons from all above the environment with telemedicine,” explained neonatologist Whit Corridor, M.D. “Telemedicine has been a massive benefit for us [in the NICU], ranging from 24/7 consultations with neonatologists and obstetrictians, census rounds, nursing consults and back transports.”
“It was these kinds of an honor to fulfill with health care leaders from all-around the earth, who shared the recent point out of health treatment worries in their countries,” said Becky Sartini, DNP, assistant director of nursing for ladies and infants expert services. “As we shared the astounding state of the perform we do below at UAMS with our innovative answers and engineering, noticing how it all is translatable to so a lot of other spots and countries just validates the prospective influence we have on not just Arkansas, but wellbeing treatment around the globe.”
Other presentations integrated the Higher-Threat Being pregnant Method and UAMS HealthNow, a virtual urgent treatment services that connects individuals with suppliers. The company was a important connector throughout the COVID-19 pandemic, with more than 100,000 visits.
Whit Hall, M.D. (at remaining) speaks to website visitors about the technologies utilized in the UAMS NICU.Benjamin Waldrum
White River Clinical Center in Batesville hosted the 2nd day’s events, centered on trauma digital wellness and IDHI courses helping with stroke expert services and sexual assault nurse examiners, as well as a tour of the unexpected emergency department.
Attendees returned to Little Rock for the 3rd and ultimate working day. Just before returning household, they toured the UAMS Simulation Heart and saw a demonstration of the 4K-resolution virtual dissection SECTRA Table. The function shut with an overview of BioVentures LLC, the know-how licensing business and business incubator based at UAMS.
“We are honored that USTTI and this assorted team of global people chose to vacation from so considerably absent to see how UAMS has carried out telemedicine and digital health and fitness to assistance rural communities in Arkansas,” reported Wendy Ross, IDHI director of packages and co-director for the South Central Telehealth Source Middle. “The finding out has long gone the two ways, of course, and we are inspired by our visitors’ passion to increase overall health outcomes in their own nations.”
The United States Telecommunications Instruction Institute (USTTI) is a nonprofit, government-business joint enterprise created to meet the IT, telecommunications, cybersecurity and satellite education desires of the females and men who design and style, regulate and oversee the communications infrastructures of the acquiring globe. Because 1982, the USTTI has graduated about 10,000 communications officers, regulators and business owners from 177 building international locations.
USTTI delivers tuition-free of charge courses in person, and by means of webinars, in the parts of regulatory coverage, 5G, spectrum management, wi-fi technologies, cybersecurity, unexpected emergency communications, world wide web, broadcasting, telehealth, rural connectivity, subsea cables, world-wide-web governance and satellite programs. As a result of its diverse curriculum, USTTI proceeds to showcase modern systems and companies pioneered in the United States.
After being eclipsed by immigration, crime and other issues in recent years, healthcare is moving back toward center stage in American politics.
It’s a shift that has divided Republicans, leaving them open to a surprisingly effective drive by President Biden to position himself as the defender of Americans’ health coverage.
Republicans have backed away from talk of cutting Medicare. But even as they do, they’re facing new divisions over the government’s other huge healthcare program, Medicaid. Conservative Republicans in Washington have proposed deep cuts in the safety-net health insurance program. But in one state after another, Republican voters have backed expanding Medicaid.
The resurgence of healthcare as a prime issue has big implications, both for this summer’s expected fight over the federal debt ceiling as well as next year’s presidential election.
Newsletter
Get our Essential Politics newsletter
The latest news, analysis and insights from our politics team in D.C.
You may occasionally receive promotional content from the Los Angeles Times.
Biden made defense of Medicare a central element of last month’s State of the Union speech, helped along by Republicans who stampeded into a rhetorical trap. He followed up Thursday with the release of his budget, which proposes to secure Medicare’s long-term finances by raising taxes on Americans earning more than $400,000 a year and launching a more aggressive government effort to hold down the cost of prescription drugs.
Biden’s plan will “ask the wealthiest to pay a little more to ensure that this program is around for at least 25 more years for our seniors who need it,” White House budget director Shalanda Young told reporters in unveiling the spending plan Thursday morning.
Those proposals won’t be adopted this year or next: The Republican-controlled House isn’t about to approve a tax increase. But that’s beside the point. Biden has teed up an issue he clearly plans to run on in 2024. If he wins, look for this week’s Medicare plan to form a main element of his agenda for a second term.
Together, the two programs account for about $1 of every $4 the federal government spends. Costs have risen in recent years, especially for Medicare; spending for it is expected to climb sharply in the next decade as the baby boomers move into retirement.
Part A of Medicare — the portion that covers hospital bills — is financed by a payroll tax, which goes into a trust fund. In recent years, the program has usually paid out more than it has taken in. Unless that changes, the trust fund will be broke by 2028, the final year of the next presidential term, according to the most recent report from Medicare’s trustees. If that happened, Medicare wouldn’t be able to fully cover the people it insures.
Preventing insolvency — and putting Medicare on a stable path — will be a major task for whoever is elected president next year.
Expect to see Biden repeatedly push his Medicare plan in the coming campaign.
In 2020, healthcare divided Democrats as presidential hopefuls to Biden’s left debated ambitious government-funded universal health plans, none of which had the political support to advance once the election was over.
In 2024, Biden has a good shot at uniting Democrats around a simpler, politically safer proposition: defending the status quo by raising taxes on the most affluent Americans.
This time, it’s Republicans who face serious divisions on the issue.
What questions do you have?
Do you have a question about politics in America that you’d like the Essential Politics newsletter to address?
We’d like to hear from you, our readers, about which political topics are uppermost in your mind.
Send your suggestions to politics@latimes.com.
During President Obama‘s tenure, Republicans in the House coalesced behind a plan written by then-Rep. Paul D. Ryan (R-Wis.), which would have turned Medicare into a voucher program for future retirees, shifting a share of the cost off the federal budget and onto individuals and families. Ryan’s plan also would have made deep cuts in Medicaid.
The proposal, although backed by many conservatives, proved unpopular with the wider electorate and was eventually defeated by a bipartisan vote in the Senate. But the Ryan plan remained the dominant Republican position until 2016 and the rise of Donald Trump.
“Trump really scrambled the equation for a lot of Republicans” by opposing any cuts to Medicare or Social Security, said Dean Rosen, a Republican healthcare policy expert and former top Senate healthcare aide. That’s led to “a bit of an identity crisis that Republicans are having now” about whether the party continues to stand for restraint on public spending.
That issue already has emerged as a dividing line in the Republican presidential primary: Trump has attacked Florida Gov. Ron DeSantis over his support for Ryan’s plan, accusing him of having voted as a member of Congress to “radically cut Medicare.” He’s made a similar attack against former South Carolina Gov. Nikki Haley, who has proposed raising the retirement age and making other changes to Medicare and Social Security for future retirees.
Many of Trump’s core supporters — who tend to be older, blue-collar and rural voters — rely on Medicare and Social Security and don’t share the ideological opposition to government spending that animates more traditional conservatives.
Squeezed by both Trump and Biden, House Republicans have mostly abandoned Ryan-style reductions in Medicare costs. At the same time, however, they’ve pledged to come up with a plan to balance the federal budget without raising taxes and have threatened to block an increase in the federal debt limit this summer to force Democrats to accept spending cuts.
To meet their goal without touching Medicare, conservatives have been looking at deep cuts in Medicaid.
From the Republican perspective, “it’s important to have this discussion” about how to restrain public spending on healthcare, Rosen said. “Unlimited spending is irresponsible.” Politically, however, “the president has a very strong hand” because he’s defending existing spending, while Republicans are proposing taking something away, he noted.
“That’s more difficult to sell politically.”
One Republican proposal would save billions of dollars by eliminating the part of the Affordable Care Act, Obama’s healthcare reform law, that allowed states to expand Medicaid to cover the working poor, with Washington picking up 90{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of the cost.
But Republicans may find that road blocked as well. In 2017, the popularity of Medicaid was one of the factors that doomed the GOP effort to repeal the Affordable Care Act. Since then, eight more states have expanded Medicaid, including solidly conservative places such as Idaho, Nebraska and Oklahoma.
This month, Republican legislators in North Carolina, after years of debate, dropped their opposition to Medicaid expansion, a big victory for Democratic Gov. Roy Cooper, who has pushed for the move. If the plan passes in the summer, as expected, North Carolina will become the 40th state to expand Medicaid, providing coverage to 600,000 residents, including many blue-collar, rural Republicans.
As “the symbolism of Obamacare has faded,” it’s become much harder for Republicans to reject Medicaid expansion under the healthcare law, said Larry Levitt, executive vice president for healthcare policy at the Kaiser Family Foundation, which has tracked the expansion debate. That’s become especially true as rural hospitals have struggled to survive in states that have not adopted expansion, a problem for Republicans, who have increasingly become the party of rural America.
“Medicaid covers more people than Medicare or Social Security,” Levitt noted. “It’s now part of the same third rail of American politics.”
“It seems Republicans have backed themselves into quite a corner.”
Fox News defamation case
Fox News anchor Maria Bartiromo is front and center in Dominion’s defamation suit
How do you solve a problem like Maria Bartiromo? Fox News executives may be asking themselves that question as she emerges as a central figure in Dominion Voting Systems’ $1.6-billion defamation suit against the conservative news network. In released court documents and deposition testimony connected to the case, Bartiromo is cited throughout for allowing Trump’s false claims about 2020 election fraud to air on the network in an effort to stop angry viewers from abandoning the network, Stephen Battaglio reports.
Check out “The Times” podcast for essential news and more.
These days, waking up to current events can be, well, daunting. If you’re seeking a more balanced news diet, “The Times” podcast is for you. Gustavo Arellano, along with a diverse set of reporters from the award-winning L.A. Times newsroom, delivers the most interesting stories from the Los Angeles Times every Monday, Wednesday and Friday. Listen and subscribe wherever you get your podcasts.
The latest from the campaign trail
Are Californians fleeing ‘woke’ policies and moving to Florida, as DeSantis claims?
DeSantis delivered a well-rehearsed blast at California this week, calling it too left, too woke, too expensive. And as proof, he declared, Californians and residents of other liberal states were leaving in droves for Florida. Is what DeSantis said true? As the saying goes, “It’s complicated,” Don Lee reports. Among other facts: For every six Californians who left for Florida last year, five moved into the state from Florida, according to data from Moody’s Analytics and the credit firm Equifax.
Column: Forget decency. In today’s politics it’s all about nastiness and party loyalty
In his column, Mark Barabak contrasted the Texas Republican party’s censure of Rep. Tony Gonzales, a two-term congressman from San Antonio, for backing a gun safety law with its conspicuous lack of response to Rep. Ronny Jackson‘s recent snide remarks about Biden’s minor surgery for skin cancer. Together, he writes, the events — though unrelated — say a good deal about the state of our politics and, especially, the nature of the Trumpified GOP. Forget basic human decency. What counts is pugnacity, acting out and blind, unswerving allegiance to the party line.
Enjoying this newsletter? Consider subscribing to the Los Angeles Times
Your support helps us deliver the news that matters most. Become a subscriber.
The latest from Washington
What you need to know about President Biden’s new budget
Biden unveiled a $6.8-trillion budget blueprint Thursday that included new spending on child care, education and healthcare and $5.5 trillion in proposed tax increases on wealthy Americans and corporations over the next decade. Courtney Subramanian looks at the highlights of the plan.
Administration seeks billions to stop a killer: hepatitis C
As part of its budget, the Biden administration is seeking billions of dollars for a new push to wipe out hepatitis C, a virus that has continued to kill thousands of people annually in the U.S. despite the existence of extremely effective medications that can cure the infection within months. The five-year program has been estimated to have a net cost of $5 billion over a decade, said Dr. Francis Collins, advisor to the president for special projects, Emily Alpert Reyes reports.
Are the feds ignoring Trump allies’ multi-state effort to access election systems? Experts raise alarms for 2024
After the 2020 election, Trump’s supporters organized to access federally protected election machines and copied sensitive information and software. Now, as the 2024 presidential primaries approach, it remains unclear whether any federal agency has plans for a comprehensive investigation of the effort, Sarah D. Wire reports. Election and law enforcement experts are concerned that the stolen information might be used to interfere with future elections and that the FBI and Justice Department may be sending the wrong signal to those responsible if agencies don’t investigate.
Biden to spotlight gun control in Monterey Park and meet U.K., Australia leaders in San Diego
Biden will travel to California on Monday for a multiday visit that will include a stop in Monterey Park, the site of one of three mass shootings that rocked the state in January, Subramanian reports. Before visiting Monterey Park, Biden will meet Monday in San Diego with Prime Ministers Rishi Sunak of Britain and Anthony Albanese of Australia to highlight the security alliance known as AUKUS.
Senate tees up vote on Garcetti’s nomination
The Senate Foreign Relations Committee voted Wednesday to advance former Los Angeles Mayor Eric Garcetti’s nomination to be ambassador to India. Garcetti’s nomination will now go to the full Senate. Majority Leader Charles E. Schumer (D-N.Y.) on Thursday started that process, making a floor vote likely next week, Nolan D. McCaskill and Jennifer Haberkorn write.
Schiff’s bid to bolster his progressive credentials for Senate run hits some resistance
Rep. Adam B. Schiff’s effort to bolster his progressive credentials in preparation for his statewide bid for Sen. Dianne Feinstein’s U.S. Senate seat has hit some resistance on Capitol Hill. On Monday, the Burbank Democrat withdrew from consideration to join a coalition of progressives in Congress after his application became divisive among the group’s members, Jennifer Haberkorn reports.
Americans are traveling abroad again, and passport wait times are skyrocketing
Attention world travelers! Check your passports, now. The State Department is taking longer than usual to issue new U.S. passports, and to renew existing passports, because record numbers of Americans are going overseas, Tracy Wilkinson reports.
The latest from California
California sues Huntington Beach over ban on housing projects
Gov. Gavin Newsom and Atty. Gen. Rob Bonta announced Thursday that the state has filed a lawsuit against Huntington Beach, alleging that the city’s ban on approving applications for certain types of housing projects is a violation of California law, Taryn Luna and Hannah Wiley report. “California is facing an existential housing crisis, one we should all be acting in unison to solve,” Bonta said at a news conference. “Instead, the Huntington Beach City Council has chosen to stifle affordable housing projects, infringe on the rights of property owners and knowingly violate state housing law.”
Newsom tests positive for COVID-19, his second infection since pandemic began
The governor tested positive Wednesday for COVID-19 after exhibiting mild symptoms, according to his spokesman Alex Stack. Newsom will work remotely and self-isolate for at least five days, Stack wrote in a text message to reporters. He added that Newsom’s wife, Jennifer Siebel Newsom, has tested negative, Laurel Rosenhall reported.
After COVID-19 school chaos, California lawmakers debate role of superintendent
When California children were stuck at home in distance learning during the COVID-19 pandemic and schools reopened unevenly across the state, raising equity concerns, frustrated parents demanded action from Supt. of Public Instruction Tony Thurmond. But unlike other states, where superintendents were leading the charge, it was Newsom who steered the pandemic response in California, negotiating with teachers unions and setting guidelines for schools. Thurmond was criticized for a lack of action. Now, two years after the governor and legislative leaders devised a multibillion-dollar plan to safely reopen schools, lingering COVID-19 frustrations could add momentum to a decades-long debate about the role of California’s superintendent of public instruction, Mackenzie Mays writes.
Sign up for our California Politics newsletter to get the best of The Times’ state politics reporting.